Summary Photodynamic therapy (PDT) is a promising approach to the local destruction of malignant tumours, but little work has been done to determine which factors control the extent of tissue necrosis produced. Using a new photosensitiser, a sulphonated aluminium phthalocyanine (AlSPc) and light from an argon ion pumped dye laser at 675 nm, we quantified the effects of interstitial PDT in a transplantable fibrosarcoma in rats. At lOOmW laser power, thermal effects were comparable to those of PDT, so subsequent studies were carried out at 50mW, where thermal effects were minimal. The depth of PDT necrosis increased with the logarithm of the applied energy. Tissue concentration of AlSPc was measured by alkali extraction and at all times after sensitisation, correlated well with the necrosis produced with a given light dose. Peak tumour concentration of AlSPc occurred 24-48h after sensitisation compared with a peak at 3h in muscle. The peak ratio tumour:muscle was 2:1 at 24h. Apart from a different time interval to reach the peak sensitiser concentration, the extent of tumour damage varied with the light and sensitiser parameters in a similar way to that found in normal liver, although the optical penetration depth was greater in the tumour (2.5mm vs. 1.8mm). At doses of AlSPc below 1 mg kg-the diameter of necrosis increased with the logarithm of the dose of sensitiser, and doubling the dose from 0.25 to 0.5 mg kg-increased the depth of necrosis by 50%. However, at higher doses, the changes were smaller and increasing the dose from 2.5 to 5mgkg-1 only increased the necrosis by 10% for the same light dose. In all dose ranges, a given percentage increase in the tissue concentration of AlSPc gave a much smaller percentage increase in the extent of necrosis for the same light dose, suggesting that selectivity of necrosis between tumour and normal tissue is likely to be much less than the selectivity of retention of the photosensitiser. From these results, the extent of PDT necrosis in this fibrosarcoma is as predictable as it is in normal liver if the light dose, tissue concentration of AlSPc and optical penetration depth of the tissue are known. Further studies are now required on different tumour models to establish how tumours respond compared with adjacent normal tissue when the tumour is growing in its organ of origin rather than the non-physiological situation using a transplantable tumour as in this study.
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Photodynamic therapy (PDT) is a method of treating tumours by the combined use of systemically administered photosensitisers and the local application of light. It has been suggested that porphyrins, in particular haematoporphyrin derivative (HpD), accumulate selectively in malignant tissue, so causing these tumours to fluoresce (Gregorie et al., 1968) . When irradiated with an appropriate wavelength of light these photosensitisers are excited to the triplet state which is then capable of reacting directly with tissue components or undergoing interaction with molecular oxygen in order to produce cytotoxic species such as singlet oxygen and free radicals (Weishaupt et al., 1976) . Most of the work reported to date has used HpD (Lipson et al., 1961) as the sensitiser, but HpD is far from ideal. It is a mixture of porphyrins, it is difficult to keep its composition the same in different batches, tumour selectivity is poor and it only has a weak absorption peak in the red area of the spectrum where tissue penetration is high. For these reasons we decided to look closer at a new group of photosensitisers, the phthalocyanines. In a recent review of phthalocyanines, Spikes (1986) suggests that these compounds could be valuable sensitisers for PDT of tumours. A number of studies have shown that various phthalocyanines (PC) will photosensitise the killing of mammalian cell lines in culture. Rosenthal (1985, 1986) have reported studies on Chinese hamster fibroblasts V-79, using chloraluminium PC(CAPC), tetrosulfo PC (TSPC) and its metal chelates. They reported that the metal free dye (TSPC) was 4 times more effective than haematoporphyrin (HP) and chelation with metal ions generally resulted in diminished photosensitising capacity except with cerium. The cerium derivative was 5 times more effective than the metal free PCs. Chan et al. (1986) used aluminium chloro sulphonated PC (AlSPc) with two murine cell lines NlH/3T3 ('normal fibroblast line') and UV-2237 (a 'transformed' fibrosarcoma line) to study cell killing and uptake of the AlSPc. Both lines behaved similarly and those sensitised with AISPc were killed more rapidly by light than those treated with a similar dose of HpD.
A number of phthalocyanines have been shown to be selectively retained in malignant tissues. Frigerio (1962) showed selective uptake of water soluble SPC in inplanted brain tumours of mice and reported a ratio tumour:normal brain of 50:1. Rousseau et al. (1983 Rousseau et al. ( , 1985 and Van Lier & Rousseau (1984) used technetium (99mTc) and gallium (67Ga) radiolabelled TSPC in the 13762 mammary adenocarcinoma of Fischer 344/CRBL rats. Tc-TSPC achieved ratios of 3.8:1 tumour: muscle at 24 h post-sensitisation and Ga-TSPC achieved a ratio of 15: 1 tumour:muscle at 6h postsensitisation. Straight and Spikes (reported in Spikes, 1986) found selective retention of zinc SPc in S180 tumours of Swiss Webster mice although the tumour:normal tissue ratio is not stated nor is the time at which maximum selectivity is found. We have shown selective retention of AlSPc in dimethylhydrazine induced colon tumours in Wistar rats, a ratio of 2:1 tumour:normal colon being found at 24-48h and we have also shown a 2:1 ratio, tumour: muscle in a fibrosarcoma of rats at 48 h as described later in this paper. Little data have yet been reported on in vivo phthalocyanine phototherapy. Spikes (1986) (Coleridge-Smith et al., 1984) . At 48 h after sensitisation with 20mgkg-1 HpD given i.v., all 3 tissues studied had a similar area of necrosis for similar light doses. Pimstone et al. (1982) showed that with haematoporphyrin sensitisation the depth of necrosis in normal liver increased with the natural logarithm of the applied energy and we showed similar results in normal liver with both HpD and AISPc sensitisation (McCubbin, 1985) . This was dissolved in 0.9% saline and administered by i.v. injection into a tail vein. Sensitised animals were kept in subdued lighting.
Pharmacodynamics of AISPc
The concentration of AlSPc was measured in tumour, adjacent muscle and skin and in plasma at various times from a few minutes to 120 h post sensitisation with 5mg kg-1 AlSPc and in tumour after sensitisation with various doses of AlSPc (0.2-25 mg kg-1). Rats were killed by cervical dislocation and -0.5g each of tumour, underlying muscle and overlying skin were removed and kept frozen at -20°C until extraction. Tissue samples were weighed, finely chopped and homogenised in 7 ml of 0.1 M NaOH for 2 min. The homogenate was centrifuged at 12,000rpm for 5min at 4°C, the clear supernatant separated, and the fluorescence read at 675nm on a spectrofluorimeter (Perkin Elmer LS-5 Luminescence Spectrophotometer) with excitation at 610nm. We have previously shown that this is an efficient extraction procedure . The effect of quenching of fluorescence of solutions of known concentrations of AISPc in 0.1 M NaOH was compared with that from the same concentrations of AISPc when present in the supernatant from the extraction procedure on unsensitised tissues. The percentage quenching found remained the same throughout the standard curve and the mean quenching for each tissue was 18% (tumour), 19% (skin) and 16% (muscle). In order to correct for this all results from sensitised tissues were calibrated against a standard curve of known concentrations of AlSPc in tissue supernatant (unsensitised) and expressed in micrograms of AISPc extracted per gram of tissue.
Phototherapy
The light source used was an argon ion pumped dye laser (Aurora-Cooper Lasersonics). The dye used was DCM (4-dicyanomethylene-2-methyl-6-(p-dimethylaminostyryl)-4H pyran in ethylene glycol and propylene carbonate) and the laser was tuned to emit light at 675 nm. The light was delivered via a 0.2mm diameter quartz fibre with a plastic coating left on to within 1 mm of the fibre end to prevent emission of light from any region other than the last 1 mm. The fibre was cleaved as often as necessary to obtain a clean circular light beam and the power checked in a power meter (photon control) prior to each treatment. Animals were anaesthetised as for sensitisation, the skin of the area surrounding the flank tumours was shaved and the tumour exposed by a single incision of the overlying skin. The size of the tumours was measured in three dimensions, using calipers, although most were roughly spherical. The 'capsule' of the tumour was pierced with a needle point and the fibre inserted into the middle of the tumour mass. Control experiments using 50 and 100 mW were done in unsensitised animals to establish the power at which purely thermal effects could be seen. Fifty mW was chosen as the power which limited thermal effects to a zone <2mm in diameter around the fibre tip and which did not cause charring. The laser was therefore set prior to fibre insertion to give a power output of 50mW at the fibre tip for the quantitative studies in sensitised animals. After exposure the fibre was removed, the skin incision sutured and the animal allowed to recover from the anaesthetic. The animals were re-anaesthetised and given an i.v. injection of Evans blue a few minutes before death (I ml 0.5% Evans in 0.9% saline) to facilitate subsequent identification of necrotic areas. Animals were killed by cervical dislocation at various times from treatment (0.1-96h) and tumour tissue removed immediately, fixed in 10% formalin, sectioned at 1 mm intervals and the maximum and minimum width of macroscopic necrosis (white area) was measured in each slice. The highest mean value (average of maximum and minimum) was recorded. Representative sections were sent for histological examination. Microscopically measured areas correlated well with those measured macroscopically. At the power level where thermal effects were negligible, experiments were carried out to investigate the effects of the following parameters on the extent of necrosis produced:
(1) Laser energy (1 to 200J), for one laser power (50mW), one dose of sensitiser (5 mg kg-1), and at one time from sensitisation to phototherapy (3 h).
(2) Dose of sensitiser (0.2 mg kg -1 to 25 mg kg-1) for one laser power (50 mW) one energy (50 J) and one time from sensitisation to phototherapy (3 h).
(3) Time from sensitisation to phototherapy (6 min to 72 h) at one dose of AISPc (5mg kg 1) and one laser power (50 mW) and one energy (50 J). The quantity of AlSPc extracted from tumour, overlying skin and underlying muscle as a function of time from sensitisation is summarised in Figure 1 and detailed in Table  I . The concentration of AlSPc peaks in tumour tissue at 24-48 h post-sensitisation whereas muscle peaks after 3 h. The total quantities are higher in skin than tumour and muscle throughout the time period studied. A similar pattern was found for skin and muscle in non-tumour animals. The maximum tumour:muscle ratio is achieved at 24-48 h and is 2:1. The plasma data is shown for comparison. An example of macroscopic tumour necrosis brought out by the Evans blue stain is shown in Figure 2 . The relationship between mean width of necrosis and applied energy (=power x time) at a power of 100 mW and 50mW is shown in Figures 3 and 4 respectively, for an AlSPc dose of 5mgkg-1 and time from sensitisation to treatment of 3 h. It can be seen that the control value (unsensitised tumour) at a power of 100mW, and energy 50J is 4.5mm mean diameter whereas the control value at 50mW for the same energy is only 2.5 mm. Thermal effects are obviously involved at lOOmW and as we wished to investigate effects due to PDT alone a power of 50 mW was used for all further work to minimise thermal necrosis. The variation of mean width of necrosis in relation to time from sensitisation to phototherapy is shown in Figure 5 . The maximum width of necrosis was seen when phototherapy was carried out 24 h post sensitisation. The effect of varying the dose of AlSPc (0.2 to 25mgkg-1) on mean width of necrosis is shown in Figure 6 . The concentration of AlSPc in tumours 3h after the administration of various doses of AlSPc (0.2 to 25 mg kg-l) is shown in Figure 7 .
The aim of this paper was to establish whether the parameters controlling the extent of PDT necrosis in malignant tissue are the same as those controlling the damage in normal tissue, that we have reported previously in studies on the liver . The factors involved can be divided into those related to the light dose and the sensitiser.
Light dose
Using the interstitial method of treatment with the laser fibre inserted into the target tumour, it is inevitable that some thermal effects will be seen in the immediate vicinity of the fibre tip. In liver, at a laser power of 100mW, thermal damage in unsensitised animals was limited to a zone about 2mm in diameter, so the greater damage seen in sensitised animals could be attributed to photodynamic effects. However, in the tumour model at the same power, the zone of necrosis increased in diameter with increasing energy even in unsensitised animals (Figure 3) showing the tumour to be more sensitive to hyperthermia than the liver. There are several possible explanations for this. These tumours are known to develop spontaneous central necrosis when over 1 cm in diameter so even when less than this size, as used in these experiments, the centre, where the fibre tip is located during therapy, may be more vulnerable to thermal damage than normal liver. Also, the high blood flow in liver may remove heat from the zone around the fibre tip more effectively, although our previous studies occluding the blood supply to the liver during phototherapy did not show any increase in thermal damage in the liver without blood flow. However, the most important conclusion from these results is that the threshold power for thermal damage varies between different organs. In our tumours, if the power was kept down to 50mW, thermal damage was limited to a zone of about 2mm in diameter, so any greater damage could be attributed to photodynamic effects. With the assumption that a threshold energy dose WT for necrosis by PDT is reached at the edge of the necrotic zone, using diffusion theory (Svassand et al., 1984) W, is related to r, the radius of the necrotic zone according to:
where WO' is the total energy dose, d is the penetration depth and A is a constant. From our previous analysis Thse use of diffusion theory is however only valid for values of r where the light distribution has become isotropic through scattering. In practice, close to the fibre tip, the distribution is not isotropic as the beam is roughly collimated as it emerges from the fibre (Svaasand & Ellingsen, 1983) . This would explain the necrosis observed at the relatively low energy of 1 J. This value of d, "2mm, may also be an underestimate due to significant absorption by the AlSPc, as discussed below. The data shown in Figure 3 for 100 mW are more difficult to interpret since thermal effects cannot be ignored and there is the possibility of charring or coagulation occurring at the fibre tip which would alter and distort the light distribution. Even though the optical penetration of light at 675 nm is greater in tumour than liver, the absolute quantity of AlSPc is less in tumour than liver (1:2.7, 3 h after 5mg kg-1 AlSPc). The size of the necrotic zone depends on both factors and in this case is slightly wider in tumour than it is in liver for the same energy (8.5 mm vs. 7.5 mm, for 100J 3h after 5mgkg-1 of AlSPc). The extent of necrosis around one treatment site can be increased with higher energies, but as the power cannot be increased without introducing thermal effects, extremely long exposure times would be necessary, and it would be much easier to treat larger volumes by using multiple treatment sites.
There have been several reports that PDT and hyperthermia are synergistic and there is certainly evidence to support this (Henderson et al., 1985) , but until the effects of both are more fully understood, we feel it is wise to restrict studies to situations in which only one form of tissue damage is investigated at a time. If the tumour to be treated is very close to the surface, the light can be delivered without the need for a fibre to be in direct contact with tissue, and a larger area can be illuminated from a single light source without the need for multiple fibres. Indeed, this is the approach taken for most experimental and clinical work with PDT. The risk of thermal effects is much less, but is certainly still present and control studies are always necessary to see whether they are occurring or not. Also, it is often difficult to achieve a uniform light intensity across an extended surface. The depth of tissue necrosis, as for interstitial treatment, will depend on the optical penetration depth, the light -fluence and the local concentration of sensitiser. Although the geometry is different, the depth of necrosis is likely to be comparable to the radius of necrosis around an interstitial fibre for similar treatment parameters. This means that for easily achieved light levels, the iepth of necrosis is likely to be less than 5mm from the surl.tec.
Sensitiser
The pattern of AlSPc accumulation in this fibrosarcoma is that of a gradual increase to a peak at 24-48 h after administration followed by an equally gradual decrease (Figure 1) . The concentration of plasma AlSPc is at its highest at 0.1 h after sensitisation: it is therefore unlikely that the tumour peak is due to plasma levels. AlSPc, which is initially bound to plasma proteins (W.S. Chan, Personal Communication) is taken up from the plasma into the tumour tissue possibly by non-specific binding of serum proteins to stromal elements and leaky vasculature (Bugelski et al., 1981) . The slow release of AlSPc from tumour tissue may be due to (i) poor lymphatic drainage (Bugelski et al., 1981) ; (ii) binding to tissue components such as (a) lipoprotein receptors (Jori et al., 1984) ; or (b) collagen and elastin (El Far & Pimstone, 1985) . However, details of the factors controlling the tissue distribution of these photosensitisers are still poorly understood.
The tumour we used is transplantable and fast growing and may behave quite differently from human neoplasms. Nevertheless, studies such as the present one require similar tumours in a large number of animals which is only possible with a tumour model such as the one used. In addition, the peak ratio of AlSPc concentration we found between tumour and muscle (2:1 at 24-48h post sensitisation) is comparable to our results for an autochthonous tumour (colon cancer induced by dimethylhydrazine in rats) in which the peak ratio between tumour and normal colon was also 2:1 at 24-48h post sensitisation . This compares well with results reported for HpD. In dimethylhydrazine induced colonic tumours of mice the ratio was 1.8:1 at 72h post i.p. administration of 10mgkg-1 HpD (Agrez et al., 1983 ) and a similar ratio, 1.8:1 (tumour:muscle), was reported in methylcholanthrene induced mammary carcinoma of mice 24h post i.p. administration of 10mgkg-1 HpD (Gomer & Dougherty, 1979) .
It is reassuring that the concentration of AlSPc measured by extraction at different times after sensitisation correlates well with the extent of the necrosis produced by a given light dose (50J at 50mW) at the same times after sensitisation (Figures 1 & 5) . The peak concentration was seen 24-48h after sensitisation, and maximum necrosis with a 24 h interval. We found the same correlation in the studies on normal liver, although in liver the maximum of both extractable concentration of AlSPc and necrosis was spread over a much longer time period.
The total dose of AlSPc influences the extent of PDT damage as shown in Figure 6 . At 0.2mgkg-1 the necrosis does not differ significantly from that in unsensitised animals, but at higher doses increases up to the maximum dose tolerated by the animals, which was 25mg kg-1. In liver, the extent of necrosis for a given light dose fell for doses above 5mg kg-due to absorption of light by the large amounts of AlSPc in the tissue which reduced the optical penetration depth. This was not seen in the tumours presumably because the dose required to achieve this was above the dose that would kill the animal by a direct toxic effect although at the higher doses of AlSPc the damage (Profio & Doiron, 1981) . At the edge of the necrosis zone of radius r, the space irradiance is given by:
where A is a constant and d is the optical penetration depth at the wavelength of the light source (Svaasand et al., 1984) .
In the case where the total delivered light dose remains constant substitution of (2) in (1) gives: (Darwent et al., 1982) .
To model the dependence of necrosis on dose when the sensitiser absorption is significant requires measurement of several parameters including the sensitiser absorption coefficient in the tissue, and the tissue absorption and scattering coefficients. The possibility of sensitiser photodecomposition should also be taken into account. These measurements have not been made, but several conclusions of practical importance can be made on the basis of the present analysis and the data in Figure 6 . Firstly, it is clear that at the higher doses of AlSPc, absorption of light by the AlSPc itself does become comparable with the tissue absorption to explain why the graph flattens at the higher doses, instead of remaining linear. This could also explain why the value of d from Figure 6 (2.5 mm) is greater than that obtained from Figure 4 (2.1 mm) as in the latter case, the dose of AlSPc used was 5mg kg-1, which is high enough for absorption by the AlSPc to be significant compared with that by the tumour itself, and so reduce the overall penetration depth. Thus, when the AlSPc dose increases from 0.25 to 0.5mgkg-1, the width of necrosis increases from 3.3 to 5.0 mm (50%). However, when the dose increases from 2.5 to 5 mg kg-1, the necrosis only rises from 6.0 to 6.6mm (10%). It can be seen from Figure 7 Figure 6 at the low doses of AlSPc where absorption by AlSPc is small compared with absorption by the tumour itself. No comparable studies have been performed with HpD, but the one other study that looked at the effect of varying the dose of sensitiser (Pimstone et al., 1982) , showed that the depth of necrosis in normal liver also increased with the logarithm of the dose of sensitiser (haematoporphyrin, in that case). However, the absorption coefficient of HpD at 630nm is much lower than that of AlSPc at 675nm, so absorption by HpD may not be comparable to that of the tissue itself until much higher tissue levels are reached. This means that tumour selectivity with HpD will not depend so critically on the dose of HpD used as is the case for AlSPc. However, high doses of HpD cause major problems of cutaneous photosensitivity, and so are best avoided if possible. In normal liver, the light energy required to produce a zone of necrosis 4mm wide is 10 times greater 3h after sensitisation with 5mgkg-1 HpD than it is 3h after the same dose of AlSPc.
El Far and Pimstone (1985) reported that a number of tumour localising porphyrins (Uroporphyrin, HpD, Photofrin II) have a high affinity for collagen and elastin and AlSPc may bind to these components of skin. A major problem of PDT using HpD is skin photosensitivity and as there are high levels of AlSPc in skin one might expect skin photosensitivity to be a major problem with this sensitiser as well. When mice were given [14C] and [3H]-HpD at a dose of 10mg kg-i.p., lower absolute levels were found in the skin (Gomer & Dougherty, 1979 ) than we found with AlSPc (5mgkg-1, i.v.). However, during our earlier experiments it was noted empirically that animals sensitised with 5mg kg-I HpD had a greater cutaneous photosensitivity reaction in room light than those sensitised with the same dose of AlSPc . Also, Chan et al. (1986) reported that cells incubated in AlSPc were killed when irradiated at 675 nm but were less sensitive to white light than cells treated with equal concentrations of HpD. Thus, the high levels of AlSPc found in skin may not be as much of a problem as would be expected, but more detailed studies of the skin response to light in sensitised animals-are required to clarify this.
In conclusion, this study has shown that the extent of PDT necrosis varies with the dose of sensitiser (AlSPc), and the laser power and exposure time in a similar way in normal liver and in a transplantable malignant tumour. It has also shown that there is good correlation of tissue damage with the tissue concentration of sensitisor at the time of phototherapy (as measured by alkali extraction). Thus it is possible to predict the extent of necrosis that will be produced with given treatment parameters in both normal and neoplastic tissue which is a significant step forward. AlSPc distribution studies have shown a peak ratio of 2:1 between fibrosarcoma and muscle and between colon cancer and normal colon which is comparable selectivity to that shown with HpD. The difference in tissue damage for a change in tissue concentration of sensitisor by a factor of 2 is greater when the absolute values of tissue levels of AlSPc are lower rather than higher, but even so, is less than 2, 1.5 being the greatest ratio shown in this study. Selective tumour destruction may be possible by other means. More selective tumour retention of the sensitiser might be achieved by administering the sensitiser in liposomes (Jori et al., 1986) or bonded to monoclonal antibodies (Mew et al., 1983 
